Compounds > 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone
Page last updated: 2024-09-03

2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Pancreatic Neoplasms

2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichikawa, E; Kamiya, D; Kato, K; Uchihata, Y; Umezawa, K1

Other Studies

1 other study(ies) available for 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Pancreatic Neoplasms

ArticleYear
Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I.
    Bioorganic & medicinal chemistry letters, 2005, Feb-15, Volume: 15, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclohexanones; Drug Resistance, Neoplasm; Glutathione; Humans; Lactoylglutathione Lyase; Pancreatic Neoplasms; Structure-Activity Relationship

2005